Company CVAbout OneSource Specialty Pharma Ltd 
OneSource Specialty Pharma Ltd
Small Cap
Pharmaceuticals & Biotechnology
Onesource Specialty Pharma Limited was incorporated as a Private Limited Company, with the name and style of `Inbiopro Solutions Private Limited' dated June 12, 2007, was issued by the Registrar of Companies, Karnataka at Bangalore. The Company name was then changed to `Stelis Biopharma Private Limited', pursuant to a Scheme of Amalgamation and a Certificate of Incorporation dated December 24, 2014, was issued by the Registrar of Companies.
Company Coordinates
No Company Details Available
Capital StructureCapital Structure
Present Equity Capital
INR None Cr
Number of Shares
None Cr
Face Value
INR None
Date
Number
of Shares(Cr)
of Shares(Cr)
Equity
Capital (Rs Cr)
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
No Details Available.
ShareholdingShareholding Snapshot
Shareholding Compare (%holding)
Majority shareholders
Promoters
Pledged Promoter Holdings
37.2322
Mutual Funds
Held by 23 Schemes (12.98%)
FIIs
Held by 144 FIIs (19.19%)
Promoter with highest holding
Tenshi Pharmaceuticals Private Limited (18.4%)
Highest Public shareholder
Motilal Oswal Mutual Fund (7.06%)
Individual Investors Holdings
11.29%
Board of Directors
Management
Designation
Remuneration
No Data
Raw MaterialsRaw Materials Dashboard
Raw Materials
Amount(Rs Cr)
% of RM Cost
Cost of Materials Consumed
405.572
0%
Cost of Materials Consumed
Finished Goods Finished Goods Dashboard
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
No Data Available for Finished Goods Segmentation
No Data Available
Stock DNARevenue and Profits:
Net Sales:
449 Cr
(Quarterly Results - Jun 2026)
Net Profit:
25 Cr
Pharmaceuticals & Biotechnology
INR 17,770 Cr (Small Cap)
NA (Loss Making)
37
0.00%
0.24
-1.10%
3.05
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
